Brief: TELA Bio Announces Clearance For Ovitex PRS Long-Term Resorbable For Plastic And Reconstructive Surgery
23/03/2023 11:28
March 23 (Reuters) - TELA Bio Inc TELA.O :
* TELA BIO ANNOUNCES 510(K) CLEARANCE FOR OVITEX PRS
LONG-TERM
RESORBABLE FOR PLASTIC AND RECONSTRUCTIVE SURGERY
Source text for Eikon: ID:nGNX5HwTdd
Further company coverage: TELA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on TELA Bio
See all newsTELA Bio Q1 revenue growth beats estimates, loss widens
Brief: TELA Bio Q1 Revenue USD 19.059 Million Vs. IBES Estimate USD 18.6 Million
Brief: Tela Bio Announces Inducement Grants Under Nasdaq Listing Rule
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly
Brief: TELA Bio Announces Pricing Of $13.0 Million Underwritten Registered Direct Offering Of Common Stock And Pre-Funded Warrants